未登录

M

Michael P. Hay

university of auckland

H指数:36

被引数:7,277

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Understanding Immune Cell Adaptation to Tumor Hypoxia for Maximized Therapeutic Efficacy of Immunotherapy: Biology and Non-invasive Imaging Application

理解免疫细胞对肿瘤低氧环境的适应以最大化免疫疗法疗效：生物学与非侵入式成像应用

Cancer Research and Treatment

IF3.8

2026-01-012

OA

Novel Prodrug Strategies for the Treatment of Tuberculosis

CHEMISTRY-AN ASIAN JOURNAL

IF3.3

2024-10-241

OAAI

The discovery of imidazo[4,5-c]pyridine-2-ones as selective inhibitors of DNA-dependent protein kinase and effective radiosensitisers

EUROPEAN JOURNAL OF CANCER

IF7.1

2024-10-010

PRE

Identification of 6-Anilino Imidazo[4,5-c]pyridin-2-ones as Selective DNA-Dependent Protein Kinase Inhibitors and Their Application as Radiosensitizers

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2024-07-150

OAAI

Targeting tumor hypoxia with prodrugs of DNA-dependent protein kinase inhibitors

CANCER RESEARCH

IF16.6

2024-01-090

PRE

Design, Synthesis and Anticancer Evaluation of Nitroimidazole Radiosensitisers

IF4.6

2023-05-312

OAAI

Hypoxia-activated prodrugs of phenolic olaparib analogues for tumour-selective chemosensitisation

RSC MEDICINAL CHEMISTRY

IF3.6

2023-01-011

OA

Spin Trapping Hydroxyl and Aryl Radicals of One-Electron Reduced Anticancer Benzotriazine 1,4-Dioxides

IF4.6

2022-01-263

OAAI

Radiosensitisation of SCCVII tumours and normal tissues in mice by the DNA-dependent protein kinase inhibitor AZD7648

RADIOTHERAPY AND ONCOLOGY

IF5.3

2022-01-0115

PRE

Characterizing and understanding the formation of cysteine conjugates and other by-products in a random, lysine-linked antibody drug conjugate

IF7.3

2021-09-052

OAAI

Subcellular Location of Tirapazamine Reduction Dramatically Affects Aerobic but Not Anoxic Cytotoxicity

Tirapazamine还原的亚细胞定位显着影响有氧但不缺氧的细胞毒性

IF4.6

2020-10-229

OAAI

Hypoxia-selective radiosensitisation by SN38023, a bioreductive prodrug of DNA-dependent protein kinase inhibitor IC87361

BIOCHEMICAL PHARMACOLOGY

IF5.6

2019-11-0124

PREAI

Benzotriazine Di-Oxide Prodrugs for Exploiting Hypoxia and Low Extracellular pH in Tumors

IF4.6

2019-07-104

OAAI

Overcoming Radioresistance: Small Molecule Radiosensitisers and Hypoxia-activated Prodrugs

CLINICAL ONCOLOGY

IF3

2019-05-0125

PREAI

Studies Towards Hypoxia-Activated Prodrugs of PARP Inhibitors

IF4.6

2019-04-1913

OAAI

Hypoxia-Activated Prodrugs of PERK Inhibitors

CHEMISTRY-AN ASIAN JOURNAL

IF3.3

2019-01-2911

PREAI

Dynamin impacts homology-directed repair and breast cancer response to chemotherapy

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2018-10-2917

OA

Cellular pharmacology of evofosfamide (TH-302): A critical re-evaluation of its bystander effects

BIOCHEMICAL PHARMACOLOGY

IF5.6

2018-10-0121

PREAI

Next-Generation Hypoxic Cell Radiosensitizers: Nitroimidazole Alkylsulfonamides

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2018-01-1154

PREAI

Chemical Space Mimicry for Drug Discovery

JOURNAL OF CHEMICAL INFORMATION AND MODELING

IF5.3

2017-04-0361

OAAI